Clinical overview of Hodgkin’s disease

  • Willem A. Kamps
  • Sibrand Poppema
  • G. Bennett Humphrey
Part of the Cancer Treatment and Research book series (CTAR, volume 41)


The purpose of this overview is not to look for consensus, not to resolve important therapeutic questions and certainly not to recommend a ‘middle of the road’ noncontroversial (a highly unlikely possibility) treatment schedule for each stage of Hodgkin’s disease. The purpose is to acknowledge that there are some very important unresolved issues and that children with Hodgkin’s disease need to be treated on research protocol [1–4].


Nitrogen Mustard Partial Splenectomy Pediatric Oncology Group Staging Laparotomy Clinical Overview 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Pringle K, Hays DM: Current management and controversies: a surgeon’s view. This volume, ch 8.Google Scholar
  2. 2.
    Hoekstra HJ, Kamps WA: Indications for staging laparotomy and partial splenectomy. This volume, ch 9.Google Scholar
  3. 3.
    Lemerle J, Oberlin O: Current management and controversies: a chemotherapist’s view. This volume, ch 10.Google Scholar
  4. 4.
    Donaldson SS: Current management and controversies: a radiotherapist’s view. This volume, ch 11.Google Scholar
  5. 5.
    Dinshaw KA, Gonsalves MA, Pande SC, et al.: Hodgkin’s disease in Indian Children. This volume, ch 16.Google Scholar
  6. 6.
    Ekert H: Treatment of childhood Hodgkin’s disease with chemotherapy alone: experiences from the Royal Children’s Hospital, Melbourne. This volume, ch 17.Google Scholar
  7. 7.
    Jenkin RDT, Doyle J: Pediatric Hodgkin’s disease: late results and toxocity—the Toronto experience. This volume, ch 18.Google Scholar
  8. 8.
    Leventhal B: Pediatric Oncology Group: studies in Hodgkin’s disease. This volume, ch 19.Google Scholar
  9. 9.
    Martin J, Radford M: Current practice in Hodgkin’s disease: United Kingdom Children’s Cancer Study Group. This volume, ch 20.Google Scholar
  10. 10.
    Sackmann-Muriel F, Maschio M, Santarelli MT, Pavlovsky S: Results of therapy for Hodgkin’s disease in childhood at Argentine Group for Treatment of Acute Leukemia. This volume, ch 21.Google Scholar
  11. 11.
    Schellong G: The German cooperative therapy studies: an approach to minimize treatment modalities and invasive staging procedures. This volume, ch 22.Google Scholar
  12. 12.
    Tan C: Hodgkin’s disease in children and adolescents: experiences from the Memorial Sloan Kettering Cancer Center, New York. This volume, ch 23.Google Scholar
  13. 13.
    Wilimas J, Thompson EI: Results of therapy for Hodgkin’s disease at St. Jude Children’s Research Hospital. This volume, ch 24.Google Scholar
  14. 14.
    Dondaldson SS, Link MP, McDougall IP, Parker BR, Shochat SJ: Clinical investigations of children with Hodgkin’s disease at Stanford University Medical Center: a preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy. This volume, ch 25.Google Scholar

Copyright information

© Kluwer Academic Publishers, Boston 1989

Authors and Affiliations

  • Willem A. Kamps
  • Sibrand Poppema
  • G. Bennett Humphrey

There are no affiliations available

Personalised recommendations